GenScript Life Science Research Grant Program was established in 2024 as an initiative dedicated to supporting breakthroughs in life science research areas, including but not limited to gene and cell therapy development, antibody drug discovery, vaccine development, diagnostics, and plant sciences. The program is designed to empower researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services. In 2025, the areas of focus for funding through the Life Science Research Grant Program will include gene and cell therapy development, antibody drug discovery, vaccine development, AI Drug Discovery, and diagnostics.